BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 11876703)

  • 1. Interactions between Helicobacter pylori and other risk factors for peptic ulcer bleeding.
    Stack WA; Atherton JC; Hawkey GM; Logan RF; Hawkey CJ
    Aliment Pharmacol Ther; 2002 Mar; 16(3):497-506. PubMed ID: 11876703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of cytotoxin-associated gene A status of Helicobacter pylori among non-steroidal anti-inflammatory drug users with peptic ulcer bleeding: a multicenter case-control study.
    Tzourmakliotis D; Economou M; Manolakopoulos S; Bethanis S; Bergele C; Lakoumentas J; Sclavos P; Milionis H; Margeli A; Vogiatzakis E; Avgerinos A
    Scand J Gastroenterol; 2004 Dec; 39(12):1180-5. PubMed ID: 15742993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for peptic ulcer bleeding in terms of Helicobacter pylori, NSAIDs, and antiplatelet agents.
    Kang JM; Kim N; Lee BH; Park HK; Jo HJ; Shin CM; Lee SH; Park YS; Hwang JH; Kim JW; Jeong SH; Lee DH; Jung HC; Song IS
    Scand J Gastroenterol; 2011 Nov; 46(11):1295-301. PubMed ID: 21815866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of peptic ulcer bleeding associated with Helicobacter pylori infection, nonsteroidal anti-inflammatory drugs, low-dose aspirin, and antihypertensive drugs: a case-control study.
    Nagata N; Niikura R; Sekine K; Sakurai T; Shimbo T; Kishida Y; Tanaka S; Aoki T; Okubo H; Watanabe K; Yokoi C; Akiyama J; Yanase M; Mizokami M; Uemura N
    J Gastroenterol Hepatol; 2015 Feb; 30(2):292-8. PubMed ID: 25339607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peptic Ulcer Bleeding Risk. The Role of Helicobacter Pylori Infection in NSAID/Low-Dose Aspirin Users.
    Sostres C; Carrera-Lasfuentes P; Benito R; Roncales P; Arruebo M; Arroyo MT; Bujanda L; García-Rodríguez LA; Lanas A
    Am J Gastroenterol; 2015 May; 110(5):684-9. PubMed ID: 25895518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for presentation with bleeding in patients with Helicobacter pylori-related peptic ulcer diseases.
    Hsu PI; Lai KH; Tseng HH; Lin CK; Lo GH; Cheng JS; Chan HH; Chen GC; Jou HS; Peng NJ; Ger LP; Chen W; Hsu PN
    J Clin Gastroenterol; 2000 Jun; 30(4):386-91. PubMed ID: 10875466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Bleeding peptic ulcer. Prevalence of Helicobacter pylori and use of nonsteroidal anti-inflammatory drugs/acetylsalicylic acid].
    Vestergård A; Bredahl K; de Muckadell OB; Pedersen OB; Hansen JM
    Ugeskr Laeger; 2009 Jan; 171(4):235-9. PubMed ID: 19174039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of ulcer bleeding in patients infected with Helicobacter pylori taking non-steroidal anti-inflammatory drugs.
    Hawkey CJ
    Gut; 2000 Mar; 46(3):310-1. PubMed ID: 10673289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bleeding peptic ulcers and presence of Helicobacter pylori by various tests: a case-control study.
    Castillo-Rojas G; Ballesteros MA; Ponce de León S; Morales-Espinosa R; Cravioto A; López-Vidal Y
    Eur J Gastroenterol Hepatol; 2002 Oct; 14(10):1113-8. PubMed ID: 12362102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Helicobacter pylori increases the risk of peptic ulcer bleeding: a case-control study.
    Labenz J; Peitz U; Köhl H; Kaiser J; Malfertheiner P; Hackelsberger A; Börsch G
    Ital J Gastroenterol Hepatol; 1999 Mar; 31(2):110-5. PubMed ID: 10363194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of Helicobacter pylori infection to the risk of peptic ulcer bleeding in patients on nonsteroidal anti-inflammatory drugs, antiplatelet agents, anticoagulants, corticosteroids and selective serotonin reuptake inhibitors.
    Venerito M; Schneider C; Costanzo R; Breja R; Röhl FW; Malfertheiner P
    Aliment Pharmacol Ther; 2018 Jun; 47(11):1464-1471. PubMed ID: 29655196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peptic ulcer bleeding in the elderly: relative roles of Helicobacter pylori and non-steroidal anti-inflammatory drugs.
    Cullen DJ; Hawkey GM; Greenwood DC; Humphreys H; Shepherd V; Logan RF; Hawkey CJ
    Gut; 1997 Oct; 41(4):459-62. PubMed ID: 9391242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome of peptic ulcer bleeding, nonsteroidal anti-inflammatory drug use, and Helicobacter pylori infection.
    Ramsoekh D; van Leerdam ME; Rauws EA; Tytgat GN
    Clin Gastroenterol Hepatol; 2005 Sep; 3(9):859-64. PubMed ID: 16234022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction between Helicobacter pylori and non-steroidal anti-inflammatory drugs in peptic ulcer bleeding.
    Wu CY; Poon SK; Chen GH; Chang CS; Yeh HZ
    Scand J Gastroenterol; 1999 Mar; 34(3):234-7. PubMed ID: 10232865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Helicobacter pylori and bleeding duodenal ulcer: prevalence of the infection and role of non-steroidal anti-inflammatory drugs.
    Gisbert JP; Gonzalez L; de Pedro A; Valbuena M; Prieto B; Llorca I; Briz R; Khorrami S; Garcia-Gravalos R; Pajares JM
    Scand J Gastroenterol; 2001 Jul; 36(7):717-24. PubMed ID: 11444470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of non-steroidal anti-inflammatory drug and aspirin use on the prevalence of dyspepsia and uncomplicated peptic ulcer disease.
    Voutilainen M; Mäntynen T; Färkkilä M; Juhola M; Sipponen P
    Scand J Gastroenterol; 2001 Aug; 36(8):817-21. PubMed ID: 11495076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Helicobacter pylori infection is a protective factor for bleeding gastric ulcers but not for bleeding duodenal ulcers in NSAID users.
    Santolaria S; Lanas A; Benito R; Pérez-Aisa Mf; Montoro M; Sainz R
    Aliment Pharmacol Ther; 1999 Nov; 13(11):1511-8. PubMed ID: 10571609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical characteristics of Helicobacter pylori-negative drug-negative peptic ulcer bleeding.
    Chung WC; Jeon EJ; Kim DB; Sung HJ; Kim YJ; Lim ES; Kim MA; Oh JH
    World J Gastroenterol; 2015 Jul; 21(28):8636-43. PubMed ID: 26229405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review article: should NSAID/low-dose aspirin takers be tested routinely for H. pylori infection and treated if positive? Implications for primary risk of ulcer and ulcer relapse after initial healing.
    Hunt RH; Bazzoli F
    Aliment Pharmacol Ther; 2004 Feb; 19 Suppl 1():9-16. PubMed ID: 14725573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of the risk factors and their combinations in acute gastroduodenal ulcer bleeding: a case-control study.
    Udd M; Miettinen P; Palmu A; Heikkinen M; Janatuinen E; Pasanen P; Tarvainen R; Mustonen H; Julkunen R
    Scand J Gastroenterol; 2007 Dec; 42(12):1395-403. PubMed ID: 17994466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.